Trial to increase the duration of neutralizing antibodies in cattle vaccinated with inactivated FMD vaccine [electronic resource].

By: Description: p.63-72Uniform titles:
  • Veterinary medical journal, 2005 v.53 (1) [electronic resource].
Subject(s): Online resources: In: Veterinary Medical Journal 2005.v.53(1)Summary: Inactivated FMD vaccine is weakly immunogenic and multiple vaccinations at four-month intervals are necessary for the prevention of the disease. Our res91ts revealed that in cyclophosphamide treated animals, the antibody titers remained pro-tecting up to 35 weeks post vaccination ,while in non treated group, the animals became suscepti¬ble to infection 19 weeks post vaccination. So, it i~ possible to il1crease the duration of neutralizing antibodies in serum when a low single dose of cy-clophosphamide is administered four days before vaccination with aluminum hydroxide-saponin FMD vaccine and this will increase the intervals between vaccinations and decrease the commer-cialization costs of vaccination programs.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Includes references.

Inactivated FMD vaccine is weakly immunogenic and multiple vaccinations at four-month intervals are necessary for the prevention of the disease. Our res91ts revealed that in cyclophosphamide treated animals, the antibody titers remained pro-tecting up to 35 weeks post vaccination ,while in non treated group, the animals became suscepti¬ble to infection 19 weeks post vaccination. So, it i~ possible to il1crease the duration of neutralizing antibodies in serum when a low single dose of cy-clophosphamide is administered four days before vaccination with aluminum hydroxide-saponin FMD vaccine and this will increase the intervals between vaccinations and decrease the commer-cialization costs of vaccination programs.

1

There are no comments on this title.

to post a comment.

Home | About ENAL | Collections | Services | Activities | Calendar | Contact us

7 Nadi El Sayed St., Gizah, Egypt | Phone: +02-33351313 | Fax: 202 33351302 | Email: enalegypt@gmail.com